世界の急性外陰膣カンジダ症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Vulvovaginal Candidiasis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0082
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、急性外陰膣カンジダ症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クロトリマゾール、ナイスタチン、フルコナゾール、ケトコナゾール、テルビナフィン、テルコナゾール、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・急性外陰膣カンジダ症治療の市場動向
・企業の競争状況、市場シェア
・急性外陰膣カンジダ症治療の種類別市場規模（クロトリマゾール、ナイスタチン、フルコナゾール、ケトコナゾール、テルビナフィン、テルコナゾール、その他）
・急性外陰膣カンジダ症治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局）
・急性外陰膣カンジダ症治療の北米市場規模2016-2027（アメリカ、カナダ）
・急性外陰膣カンジダ症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・急性外陰膣カンジダ症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・急性外陰膣カンジダ症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・急性外陰膣カンジダ症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Mycovia Pharmaceuticals, Inc、Scynexis, Inc、Basilea Pharmaceutica Ltd、Astellas Pharma Inc、Grupo Ferrer Internacional, S.A、Pacgen Life Science Corporation、NovaDigm Therapeutics, Inc、Cidara Therapeutics, Inc、Amplyx Pharmaceuticals Inc、Pfizer, Inc.）
・結論

Acute vulvovaginal candidiasis is a fungal/yeast infection, which is caused by some species of Candida, especially Candida albicans. Increasing cases of vulvovaginal candidiasis can be attributed to ageing, overuse of antibiotics, diabetes, etc. Doctors are involved in prescribing medicines on the basis of their efficiency in controlling acute vulvovaginal candidiasis among the patients.

Market Analysis and Insights: Global Acute Vulvovaginal Candidiasis Treatment Market
The global Acute Vulvovaginal Candidiasis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Vulvovaginal Candidiasis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Vulvovaginal Candidiasis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Vulvovaginal Candidiasis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Vulvovaginal Candidiasis Treatment market.

Global Acute Vulvovaginal Candidiasis Treatment Scope and Market Size
Acute Vulvovaginal Candidiasis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Vulvovaginal Candidiasis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Clotrimazole
Nystatin
Fluconazole
Ketoconazole
Terbinafine
Terconazole
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Mycovia Pharmaceuticals, Inc
Scynexis, Inc
Basilea Pharmaceutica Ltd
Astellas Pharma Inc
Grupo Ferrer Internacional, S.A
Pacgen Life Science Corporation
NovaDigm Therapeutics, Inc
Cidara Therapeutics, Inc
Amplyx Pharmaceuticals Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Vulvovaginal Candidiasis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Clotrimazole
1.2.3 Nystatin
1.2.4 Fluconazole
1.2.5 Ketoconazole
1.2.6 Terbinafine
1.2.7 Terconazole
1.2.8 Others
1.3 Market by Application
1.3.1 Global Acute Vulvovaginal Candidiasis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Vulvovaginal Candidiasis Treatment Market Perspective (2016-2027)
2.2 Acute Vulvovaginal Candidiasis Treatment Growth Trends by Regions
2.2.1 Acute Vulvovaginal Candidiasis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Vulvovaginal Candidiasis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Acute Vulvovaginal Candidiasis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Acute Vulvovaginal Candidiasis Treatment Industry Dynamic
2.3.1 Acute Vulvovaginal Candidiasis Treatment Market Trends
2.3.2 Acute Vulvovaginal Candidiasis Treatment Market Drivers
2.3.3 Acute Vulvovaginal Candidiasis Treatment Market Challenges
2.3.4 Acute Vulvovaginal Candidiasis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Vulvovaginal Candidiasis Treatment Players by Revenue
3.1.1 Global Top Acute Vulvovaginal Candidiasis Treatment Players by Revenue (2016-2021)
3.1.2 Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Acute Vulvovaginal Candidiasis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Vulvovaginal Candidiasis Treatment Revenue
3.4 Global Acute Vulvovaginal Candidiasis Treatment Market Concentration Ratio
3.4.1 Global Acute Vulvovaginal Candidiasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Vulvovaginal Candidiasis Treatment Revenue in 2020
3.5 Acute Vulvovaginal Candidiasis Treatment Key Players Head office and Area Served
3.6 Key Players Acute Vulvovaginal Candidiasis Treatment Product Solution and Service
3.7 Date of Enter into Acute Vulvovaginal Candidiasis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Vulvovaginal Candidiasis Treatment Breakdown Data by Type
4.1 Global Acute Vulvovaginal Candidiasis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Acute Vulvovaginal Candidiasis Treatment Forecasted Market Size by Type (2022-2027)

5 Acute Vulvovaginal Candidiasis Treatment Breakdown Data by Application
5.1 Global Acute Vulvovaginal Candidiasis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Acute Vulvovaginal Candidiasis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Vulvovaginal Candidiasis Treatment Market Size (2016-2027)
6.2 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Type
6.2.1 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021)
6.2.2 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2022-2027)
6.2.3 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2027)
6.3 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Application
6.3.1 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2021)
6.3.2 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2022-2027)
6.3.3 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2027)
6.4 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Country
6.4.1 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2016-2021)
6.4.2 North America Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Vulvovaginal Candidiasis Treatment Market Size (2016-2027)
7.2 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type
7.2.1 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2027)
7.3 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application
7.3.1 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2027)
7.4 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Country
7.4.1 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Type
8.2.1 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Application
8.3.1 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Region
8.4.1 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size (2016-2027)
9.2 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Type
9.2.1 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2027)
9.3 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Application
9.3.1 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2027)
9.4 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Country
9.4.1 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type
10.2.1 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application
10.3.1 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Country
10.4.1 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Mycovia Pharmaceuticals, Inc
11.1.1 Mycovia Pharmaceuticals, Inc Company Details
11.1.2 Mycovia Pharmaceuticals, Inc Business Overview
11.1.3 Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Introduction
11.1.4 Mycovia Pharmaceuticals, Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
11.1.5 Mycovia Pharmaceuticals, Inc Recent Development
11.2 Scynexis, Inc
11.2.1 Scynexis, Inc Company Details
11.2.2 Scynexis, Inc Business Overview
11.2.3 Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Introduction
11.2.4 Scynexis, Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
11.2.5 Scynexis, Inc Recent Development
11.3 Basilea Pharmaceutica Ltd
11.3.1 Basilea Pharmaceutica Ltd Company Details
11.3.2 Basilea Pharmaceutica Ltd Business Overview
11.3.3 Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Introduction
11.3.4 Basilea Pharmaceutica Ltd Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
11.3.5 Basilea Pharmaceutica Ltd Recent Development
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Details
11.4.2 Astellas Pharma Inc Business Overview
11.4.3 Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Introduction
11.4.4 Astellas Pharma Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
11.4.5 Astellas Pharma Inc Recent Development
11.5 Grupo Ferrer Internacional, S.A
11.5.1 Grupo Ferrer Internacional, S.A Company Details
11.5.2 Grupo Ferrer Internacional, S.A Business Overview
11.5.3 Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Introduction
11.5.4 Grupo Ferrer Internacional, S.A Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
11.5.5 Grupo Ferrer Internacional, S.A Recent Development
11.6 Pacgen Life Science Corporation
11.6.1 Pacgen Life Science Corporation Company Details
11.6.2 Pacgen Life Science Corporation Business Overview
11.6.3 Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Introduction
11.6.4 Pacgen Life Science Corporation Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
11.6.5 Pacgen Life Science Corporation Recent Development
11.7 NovaDigm Therapeutics, Inc
11.7.1 NovaDigm Therapeutics, Inc Company Details
11.7.2 NovaDigm Therapeutics, Inc Business Overview
11.7.3 NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Introduction
11.7.4 NovaDigm Therapeutics, Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
11.7.5 NovaDigm Therapeutics, Inc Recent Development
11.8 Cidara Therapeutics, Inc
11.8.1 Cidara Therapeutics, Inc Company Details
11.8.2 Cidara Therapeutics, Inc Business Overview
11.8.3 Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Introduction
11.8.4 Cidara Therapeutics, Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
11.8.5 Cidara Therapeutics, Inc Recent Development
11.9 Amplyx Pharmaceuticals Inc
11.9.1 Amplyx Pharmaceuticals Inc Company Details
11.9.2 Amplyx Pharmaceuticals Inc Business Overview
11.9.3 Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Introduction
11.9.4 Amplyx Pharmaceuticals Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
11.9.5 Amplyx Pharmaceuticals Inc Recent Development
11.10 Pfizer, Inc.
11.10.1 Pfizer, Inc. Company Details
11.10.2 Pfizer, Inc. Business Overview
11.10.3 Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Introduction
11.10.4 Pfizer, Inc. Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
11.10.5 Pfizer, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Vulvovaginal Candidiasis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Clotrimazole
Table 3. Key Players of Nystatin
Table 4. Key Players of Fluconazole
Table 5. Key Players of Ketoconazole
Table 6. Key Players of Terbinafine
Table 7. Key Players of Terconazole
Table 8. Key Players of Others
Table 9. Global Acute Vulvovaginal Candidiasis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Acute Vulvovaginal Candidiasis Treatment Market Share by Regions (2016-2021)
Table 13. Global Acute Vulvovaginal Candidiasis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Acute Vulvovaginal Candidiasis Treatment Market Share by Regions (2022-2027)
Table 15. Acute Vulvovaginal Candidiasis Treatment Market Trends
Table 16. Acute Vulvovaginal Candidiasis Treatment Market Drivers
Table 17. Acute Vulvovaginal Candidiasis Treatment Market Challenges
Table 18. Acute Vulvovaginal Candidiasis Treatment Market Restraints
Table 19. Global Acute Vulvovaginal Candidiasis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Acute Vulvovaginal Candidiasis Treatment Market Share by Players (2016-2021)
Table 21. Global Top Acute Vulvovaginal Candidiasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Vulvovaginal Candidiasis Treatment as of 2020)
Table 22. Ranking of Global Top Acute Vulvovaginal Candidiasis Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Acute Vulvovaginal Candidiasis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Acute Vulvovaginal Candidiasis Treatment Product Solution and Service
Table 26. Date of Enter into Acute Vulvovaginal Candidiasis Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Acute Vulvovaginal Candidiasis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Acute Vulvovaginal Candidiasis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Acute Vulvovaginal Candidiasis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. Mycovia Pharmaceuticals, Inc Company Details
Table 67. Mycovia Pharmaceuticals, Inc Business Overview
Table 68. Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Product
Table 69. Mycovia Pharmaceuticals, Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021) & (US$ Million)
Table 70. Mycovia Pharmaceuticals, Inc Recent Development
Table 71. Scynexis, Inc Company Details
Table 72. Scynexis, Inc Business Overview
Table 73. Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Product
Table 74. Scynexis, Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021) & (US$ Million)
Table 75. Scynexis, Inc Recent Development
Table 76. Basilea Pharmaceutica Ltd Company Details
Table 77. Basilea Pharmaceutica Ltd Business Overview
Table 78. Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Product
Table 79. Basilea Pharmaceutica Ltd Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021) & (US$ Million)
Table 80. Basilea Pharmaceutica Ltd Recent Development
Table 81. Astellas Pharma Inc Company Details
Table 82. Astellas Pharma Inc Business Overview
Table 83. Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Product
Table 84. Astellas Pharma Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021) & (US$ Million)
Table 85. Astellas Pharma Inc Recent Development
Table 86. Grupo Ferrer Internacional, S.A Company Details
Table 87. Grupo Ferrer Internacional, S.A Business Overview
Table 88. Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Product
Table 89. Grupo Ferrer Internacional, S.A Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021) & (US$ Million)
Table 90. Grupo Ferrer Internacional, S.A Recent Development
Table 91. Pacgen Life Science Corporation Company Details
Table 92. Pacgen Life Science Corporation Business Overview
Table 93. Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Product
Table 94. Pacgen Life Science Corporation Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021) & (US$ Million)
Table 95. Pacgen Life Science Corporation Recent Development
Table 96. NovaDigm Therapeutics, Inc Company Details
Table 97. NovaDigm Therapeutics, Inc Business Overview
Table 98. NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product
Table 99. NovaDigm Therapeutics, Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021) & (US$ Million)
Table 100. NovaDigm Therapeutics, Inc Recent Development
Table 101. Cidara Therapeutics, Inc Company Details
Table 102. Cidara Therapeutics, Inc Business Overview
Table 103. Cidara Therapeutics, Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021) & (US$ Million)
Table 104. Cidara Therapeutics, Inc Recent Development
Table 105. Amplyx Pharmaceuticals Inc Company Details
Table 106. Amplyx Pharmaceuticals Inc Business Overview
Table 107. Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Product
Table 108. Amplyx Pharmaceuticals Inc Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021) & (US$ Million)
Table 109. Amplyx Pharmaceuticals Inc Recent Development
Table 110. Pfizer, Inc. Company Details
Table 111. Pfizer, Inc. Business Overview
Table 112. Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Product
Table 113. Pfizer, Inc. Revenue in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021) & (US$ Million)
Table 114. Pfizer, Inc. Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Vulvovaginal Candidiasis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Clotrimazole Features
Figure 3. Nystatin Features
Figure 4. Fluconazole Features
Figure 5. Ketoconazole Features
Figure 6. Terbinafine Features
Figure 7. Terconazole Features
Figure 8. Others Features
Figure 9. Global Acute Vulvovaginal Candidiasis Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Acute Vulvovaginal Candidiasis Treatment Report Years Considered
Figure 14. Global Acute Vulvovaginal Candidiasis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Acute Vulvovaginal Candidiasis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Acute Vulvovaginal Candidiasis Treatment Market Share by Regions: 2020 VS 2027
Figure 17. Global Acute Vulvovaginal Candidiasis Treatment Market Share by Regions (2022-2027)
Figure 18. Global Acute Vulvovaginal Candidiasis Treatment Market Share by Players in 2020
Figure 19. Global Top Acute Vulvovaginal Candidiasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Vulvovaginal Candidiasis Treatment as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Acute Vulvovaginal Candidiasis Treatment Revenue in 2020
Figure 21. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Type (2016-2021)
Figure 22. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Type (2022-2027)
Figure 23. North America Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Acute Vulvovaginal Candidiasis Treatment Market Share by Type (2016-2027)
Figure 25. North America Acute Vulvovaginal Candidiasis Treatment Market Share by Application (2016-2027)
Figure 26. North America Acute Vulvovaginal Candidiasis Treatment Market Share by Country (2016-2027)
Figure 27. United States Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Acute Vulvovaginal Candidiasis Treatment Market Share by Type (2016-2027)
Figure 31. Europe Acute Vulvovaginal Candidiasis Treatment Market Share by Application (2016-2027)
Figure 32. Europe Acute Vulvovaginal Candidiasis Treatment Market Share by Country (2016-2027)
Figure 33. Germany Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Acute Vulvovaginal Candidiasis Treatment Market Share by Region (2016-2027)
Figure 43. China Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Acute Vulvovaginal Candidiasis Treatment Market Share by Type (2016-2027)
Figure 51. Latin America Acute Vulvovaginal Candidiasis Treatment Market Share by Application (2016-2027)
Figure 52. Latin America Acute Vulvovaginal Candidiasis Treatment Market Share by Country (2016-2027)
Figure 53. Mexico Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Share by Country (2016-2027)
Figure 59. Turkey Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Acute Vulvovaginal Candidiasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Mycovia Pharmaceuticals, Inc Revenue Growth Rate in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
Figure 63. Scynexis, Inc Revenue Growth Rate in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
Figure 64. Basilea Pharmaceutica Ltd Revenue Growth Rate in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
Figure 65. Astellas Pharma Inc Revenue Growth Rate in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
Figure 66. Grupo Ferrer Internacional, S.A Revenue Growth Rate in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
Figure 67. Pacgen Life Science Corporation Revenue Growth Rate in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
Figure 68. NovaDigm Therapeutics, Inc Revenue Growth Rate in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
Figure 69. Cidara Therapeutics, Inc Revenue Growth Rate in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
Figure 70. Amplyx Pharmaceuticals Inc Revenue Growth Rate in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
Figure 71. Pfizer, Inc. Revenue Growth Rate in Acute Vulvovaginal Candidiasis Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の急性骨髄性白血病（AML）治療市場規模・現状・予測（2021年-2027年）

Global Acute Myeloid Leukemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0074 2021年4月 99Pages
QYResearch社発行の本調査資料では、急性骨髄性白血病（AML）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（DCレジメン、AVDレジメン、VCDレジメン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の急性虚血性脳卒中診断・治療市場規模・現状・予測（2021年-2027年）

Global Acute Ischemic Stroke Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0062 2021年4月 98Pages
QYResearch社発行の本調査資料では、急性虚血性脳卒中診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コンピュータ断層撮影（CT）、磁気共鳴画像法（MRI）、頸部超音波、脳血管造影、心電図、心エコー検査、その他）、用途別市場規模...

世界の急性侵襲性アスペルギルス症治療市場規模・現状・予測（2021年-2027年）

Global Acute Invasive Aspergillosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0061 2021年4月 91Pages
QYResearch社発行の本調査資料では、急性侵襲性アスペルギルス症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗真菌剤）、用途別市場規模（病院、オンライン、小売）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界の急性感音難聴治療市場規模・現状・予測（2021年-2027年）

Global Acute Sensorineural Hearing Loss Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0079 2021年4月 98Pages
QYResearch社発行の本調査資料では、急性感音難聴治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（全身ステロイド、抗ウイルス薬、血管拡張薬、炭素療法、その他）、用途別市場規模（病院、耳科クリニック、外来クリニック）、主要地域別市場規模...

世界の急性リンパ性白血病（ALL）治療市場規模・現状・予測（2021年-2027年）

Global Acute Lymphoid Leukemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0071 2021年4月 94Pages
QYResearch社発行の本調査資料では、急性リンパ性白血病（ALL）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、放射線療法、骨髄移植、免疫療法、その他）、用途別市場規模（成人、子供）、主要地域別市場規模（北米、ア...

世界の急性リンパ芽球性白血病（ALL）治療市場規模・現状・予測（2021年-2027年）

Global Acute Lymphoblastic Leukemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0067 2021年4月 134Pages
QYResearch社発行の本調査資料では、急性リンパ芽球性白血病（ALL）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、放射線療法、幹細胞移植）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の急性リンパ性/リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年）

Global Acute Lymphocytic/Lymphoblastic Leukemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0070 2021年4月 126Pages
QYResearch社発行の本調査資料では、急性リンパ性/リンパ芽球性白血病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、放射線療法、幹細胞移植）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0059 2021年4月 90Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の急性・慢性異常子宮出血（AUB）市場規模・現状・予測（2021年-2027年）

Global Acute and Chronic Abnormal Uterine Bleeding Market Size, Status and Forecast 2021-2027
QYR2104Z0051 2021年4月 93Pages
QYResearch社発行の本調査資料では、急性・慢性異常子宮出血（AUB）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、非ホルモン療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…
世界の急性中耳炎治療市場 2021：企業別、地域別、種類・用途別 The Acute Otitis Media Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
世界の急性侵襲性アスペルギルス症治療市場規模・現状・予測（2021年-2027年） Acute Invasive Aspergillosis is an acute infection or fungal growth, which arises due to Aspergillus fungus. Market Analysis and Insights: Global Acute Invasive Aspergillosis Treatment Market The global Acute Invasive Aspergillosis Treatment market size is projected to reach US$ XX million by 2027, …
世界の急性骨髄性白血病（AML）治療市場規模・現状・予測（2021年-2027年） Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90…
世界の急性虚血性脳卒中診断・治療市場規模・現状・予測（2021年-2027年） According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. Market Analysis and Insights: Global Acute Ischemic Stroke Diagnosis and Treatment Market The global Acute Ischemic Stroke Diagnosis and Treatment market size is projected…